ArticleHandbook of experimental pharmacology2022

Preclinical Studies on Nalfurafine (TRK-820), a Clinically Used KOR Agonist.

Yan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.